The widespread occurrence of vicinal amino alcohols means that efficient and reliable methods for their preparation are important. A powerful approach lies in the direct oxidation of an olefin by introduction of oxygen and nitrogen groups *via* an aminohydroxylation.^[@ref1],[@ref2]^ However, one drawback to alkene aminohydroxylation is the unpredictable regiochemical outcome; this can be highly dependent on the nature of the alkene substrate.^[@ref2]^ We recognized that tethering the nitrogen source to an allylic alcohol would ensure complete control of regioselectivity in a subsequent osmium catalyzed aminohydroxylation, a tethered aminohydroxylation (TA). Since our early reports,^[@ref3]^ we have disclosed significant improvements to the process through discovery of new nitrogen reoxidants for TA, using *N*-sulfonyloxycarbamates^[@ref4]^ and *N*-aroyloxycarbamates.^[@ref5],[@ref6]^ The use of such N--O based oxidants avoids the use of *t-*BuOCl (a common reoxidant in aminohydroxylation) and prevents any unwanted alkene chlorination. Thus, the TA can be used for the regio- and stereoselective aminohydroxylation of substituted alkene substrates in high yields and with low catalyst loadings.

In order to examine the applicability of the TA reaction in the synthesis of complex targets,^[@ref7]^ we selected a β-amino acid from the microsclerodermin family, namely a polyhydroxylated amino acid containing five contiguous stereocenters, named AMMTD (Figure [1](#fig1){ref-type="fig"}).

![Microsclerodermins A and B.](ol-2013-02638n_0001){#fig1}

Microsclerodermins (A--K) are a family of cyclic hexapeptides isolated from the lithistid marine sponges *Microscleroderma* sp., *Theonella* sp., and *Microscleroderma herdmani*,^[@ref8],[@ref9]^ which demonstrate antifungal activity and cytotoxicity against an HCT-116 cell line. The most complex residue is a β-amino acid with either four or five contiguous stereocenters and variation in the degree of unsaturation in the side-chain tail. Early studies on the microsclerodermins by Shioiri^[@ref10]^ were followed by Ma who reported the only total synthesis of any microsclerodermin (E, containing a β-amino acid with four contiguous stereocenters).^[@ref11]^ Shioiri^[@ref12]^ and Chandrasekhar^[@ref13]^ reported the synthesis of protected variants of the β-amino acid in microsclerodermins A and B (AMMTD), while the simpler β-amino acid of microsclerodermins C and D (APTO) and E (AETD) have received the most attention.^[@ref14]^

It was essential that our approach to AMMTD (Scheme [1](#sch1){ref-type="scheme"}) produced the target in a form that would permit conjugation to other amino acids, ultimately allowing a total synthesis of the microsclereodermins. Another fundamental part of our design was late-stage introduction of the aliphatic tail, to allow access to multiple members of the family. We envisaged side-chain installation *via* organocuprate addition to functionalized electrophile **III**. The key aminohydroxyl unit at C2,C3 could be installed *via* a regio- and stereoselective aminohydroxylation of an olefin *via* TA reaction of **II**. Precursor **II** could arise from manipulation of a diol, generated by dihydroxylation (AD) of α,β,γ,δ-unsaturated ester **I**. In turn diene **I** should be readily prepared as a single enantiomer from (*S*)-Roche ester.

![Retrosynthetic Analysis of AMMTD](ol-2013-02638n_0002){#sch1}

The first step involved formation of benzyl ether **2** by reaction of **1** with benzyl 2,2,2-trichloroacetimidate, followed by reduction to aldehyde **3** (Scheme [2](#sch2){ref-type="scheme"}).^[@ref15]^ The crude aldehyde was transfomed into (*E*,*E*)-diene **5** through (*E*)-selective Horner--Wadsworth--Emmons reaction with phosphonate **4**. We found that the desired olefination proceeded efficiently utilizing 2 equiv of phosphonate and LDA at −20 °C. This allowed for the formation of diene **5** in good yield (67%, three steps) as an (inseparable) (*E*,*E*)/(*E*,*Z*) 9:1 mixture and as a single enantiomer (ee \>90%, by Mosher's ester analysis).

![Construction of Diene **5**](ol-2013-02638n_0003){#sch2}

Installation of the C4,C5 diol proceeded *via* regio- and stereoselective dihydroxylation of diene **5** under Sharpless AD conditions, exploiting preferential reaction at the more electron rich alkene (Scheme [3](#sch3){ref-type="scheme"}).^[@ref16]^ Reaction of **5** with AD mix-α gave diol **6** as a single diastereoisomer^[@ref17]^ (stereoselectivity assigned by the Sharpless mnemonic^[@ref18]^). The preferential rate of dihydroxylation of (*E*)-1,2- over (*Z*)-1,2-disubstituted olefins^[@ref19]^ meant that the minor unreacted (*E*,*Z*)-diene isomer could be easily removed.

![Formation of TA Precursor **9**](ol-2013-02638n_0004){#sch3}

The TA sequence required differentiation between the two alcohols in **6**. This was accomplished by formation of cyclic acetal **7**, using benzaldehyde dimethyl acetal with one-pot ester reduction using DIBAL-H (83%).^[@ref20]^ We envisaged that the benzyl ether of **7** might coordinate to a Lewis acid and encourage regioselective opening of the acetal. Treatment of **7** with TiCl~4~ and triethylsilane generated monoprotected benzyl ether **8** in 79% yield (regiochemistry confirmed by HMBC analysis).^[@ref21]^ The TA precursor was then prepared by selective protection of the primary alcohol as a TBS ether, allowing the secondary alcohol to be transformed *via* treatment with CDI and hydroxylamine hydrochloride, followed by mesitoylation to afford intermediate **9**.

The key transformation (the TA) was now addressed (Scheme [4](#sch4){ref-type="scheme"}). Treatment of **9** with 1 or 2 mol % potassium osmate hardly converted the substrate, presumably because of steric hindrance. An increase in catalyst loading to 5 mol % proved beneficial, and the desired aminohydroxylated product **10** was isolated in a yield of 76% at 40 °C. Notably, and consistent with previous observations, compound **10** was isolated as a single diastereoisomer, *via* a 1,3-*anti* TA reaction.^[@ref5]^ The structure was confirmed by transformation into a solid, **12**, and X-ray diffraction studies.^[@ref22]^ At this stage we had prepared a compound (**10**) with the five contiguous stereocenters of AMMTD in place over 10 steps in 17% overall yield.

![Tethered Aminohydroxylation (TA) of **9**](ol-2013-02638n_0005){#sch4}

In order to append the aliphatic side chain (*via* addition of an organocuprate), diol **11** was converted to primary iodide **14**, *via* selective formation of the iodide at C7 (84%) and protection of the C4 hydroxyl (91%), again as a TBS ether (Scheme [5](#sch5){ref-type="scheme"}). As part of our overall strategy we elected to prepare an organocuprate from 5-iodo-1-pentene (a side chain that bore a terminal olefin for flexibility later on). The generation of an organometallic reagent from one primary iodide, and subsequent displacement within a second primary iodide (which itself contained an acidic proton) proved to be extremely challenging. Extensive experimentation allowed us to make the following observations: (i) preparation of the organolithium from pentenyl iodide was best accomplished with *t*-BuLi; (ii) organolithium formation required ether solvent, while cuprate formation and subsequent displacement of **14** required THF solvent; (iii) CuCN was the best source of copper;^[@ref23]^ (iv) addition of LiCl increased the solubility of the Lipshutz cuprate providing improved reproducibility; (v) temperature control during the reaction was essential, with organolithium formation being best at −78 °C with warming to room temperature, while transmetalation and displacement were optimal at −40 °C (Table [1](#tbl1){ref-type="other"}).

![Synthesis of Iodide **14** and Side Chain Installation](ol-2013-02638n_0006){#sch5}

###### Optimization of Organocuprate Addition to **14**

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  entry   formation of\                                      additive[b](#t1fn2){ref-type="table-fn"}   temp\                                  **15**,\
          pentenyl lithium[a](#t1fn1){ref-type="table-fn"}                                              (°C)[c](#t1fn3){ref-type="table-fn"}   yield %
  ------- -------------------------------------------------- ------------------------------------------ -------------------------------------- -----------------------------------
  1       Li metal[d](#t1fn4){ref-type="table-fn"}           CuCN                                       --40                                   50

  2       *t*-BuLi                                           CuCN                                       --40                                   77

  3       *t*-BuLi                                           CuCN                                       --20                                   30

  4       *t*-BuLi[d](#t1fn4){ref-type="table-fn"}           CuCN                                       --40                                   0[e](#t1fn5){ref-type="table-fn"}

  5       *t*-BuLi                                           CuCN/LiCl                                  --40                                   80--97
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

4-Pentenyl iodide used as anion precursor in Et~2~O.

Anion transferred to the copper source in THF.

Temperature for anion formation −78 °C then warm to rt for 1 h.

4-Pentenyl bromide used as anion precursor in ether.

Iodide **14** was recovered.

In order to deliver the amino acid in a form suitable for a later total synthesis, we cleaved the carbamate generated in the TA reaction (Scheme [6](#sch6){ref-type="scheme"}). This was accomplished *via* initial activation of **15** as its *N*-Boc derivative (Boc~2~O/DMAP, 95%). We found sodium *tert*-butoxide in *t*-BuOH/THF then brought about the desired cleavage in high yield (87%). Interestingly, the product **16** derived from C4-to-C5 migration of the TBS group (9:1 mixture) was isolated from the cleavage reaction. We were unable to reprotect the regioisomeric mixture as TBS ethers (to generate a single compound) and so continued by selective deprotection of the primary TBS ether, using HF/pyridine (75%).^[@ref24]^ At this stage the regioisomers were separable, allowing **17** to be isolated as a single compound. We now sought to oxidize the C1 hydroxyl and found the most reliable procedure involved oxidation of **17** under Parikh--Doering conditions, which cleanly gave lactone **18**. To prepare AMMTD, we required transformation of the terminal olefin into an (*E*)-*p*-methoxy styrene *via* cross-metathesis.^[@ref25]^ Therefore, treatment of terminal alkene **18** and 4-vinylanisole (5 equiv) with sequential additions of Grubbs I catalyst (3 × 5 mol %) afforded (*E*)-styrene **19** in 88% yield, thus completing the synthesis of the fully protected β-amino acid AMMTD. Finally, we decided to test the effectiveness of the lactone as an activated carbonyl for amide formation. Treatment of **19** with a branched primary amine (cyclopentylamine, chosen as a model for the pyrrolidinone amino acid in the microsclerodermins), in the presence of 2-hydroxypyridine,^[@ref26]^ generated amide **20** in 92% yield. In addition, reaction of aniline (selected since aniline amides have been shown to be excellent precursors to carboxylic acids *via* hydrolysis under mild conditions^[@ref27]^) and trimethylaluminium also opened the lactone to deliver amide **21** in 78% yield.

![Completion of the Synthesis of Protected AMMTD](ol-2013-02638n_0007){#sch6}

In conclusion, we have demonstrated the synthetic utility of the tethered aminohydroxylation *via* the regio- and stereoselective functionalization of a complex homoallylic alcohol, serving as a key step in the synthesis of β-amino acid AMMTD. Moreover, we have designed our route to incorporate a late-stage introduction of the aliphatic side chain, a tactic that should allow access to other β-amino acid members of the microsclerodermins.
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